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Introduction
Hemangioblastomas of the central nervous system(CNS)are highly vascular, benign, and well-circumscribed
solid or cystic neoplasms, which constitute 1% to 2.5% of all
intracranial neoplasms10,11,17). They are predominantly located
in the cerebellum, but can also be found in other regions of the
CNS. Hemangioblastomas can present as sporadic lesions or
as manifestations of von Hippel-Lindau(VHL) disease, which
is an autosomal dominant hereditary disease characterized by
the neoplasm arising in multiple organs including the eye,
kidneys, pancreas, adrenal glands, epididymis and the CNS7,11).
They are histologically benign and grow slowly. However,
they can cause significant morbidity and mortality as a result
of a mass effect on the nearby structures3,10). They are often
multiple, as is commonly encountered in VHL disease. In
addition, multiple lesions are serious because they occur in
the narrow space of the posterior fossa. The treatment of
choice for hemangioblastomas is a total surgical resection,
and radiosurgery can be an alternative or adjuvant treatment
modality1,6,12). In this study, we reviewed the experiences
about the management of multiple hemangioblastomas in
posterior fossa which were treated by surgery and radiosurgery.
Materials and Methods 
Patient selection
Seventy-eight CNS hemangioblastoma patients were treated
in our hospital from January 1990 to June 2004. A single CNS
lesion or multiple spinal cord lesions were excluded. Then
nine patients who had multiple tumors in the posterior cranial
fossa were reviewed retrospectively. A total of 87 lesions were
treated. All the patients were diagnosed as VHL disease due
to multiple CNS hemangioblastomas7,8). There were five men
and four women with a mean age of 40.0years (19~53years).
A surgical resection was performed for all patients and the
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pathology was demonstrated to be a hemangioblastoma.
Magnetic resonance(MR) imaging was available for all the
patients, and the mean follow up duration was 75.7months
(6.6~159.2months).
Surgical resection
A total of 16 lesions were treated with surgical resection. The
lateral suboccipital approach or midline suboccipital approach
was used. Four patients underwent two times of surgical resec-
tions.
Radiosurgery
A total of 81 lesions were treated with Gamma Knife radio-
surgery (GKS, 201-source cobalt-60 gamma unit, Elekta Ins-
truments), and each patient had a mean number of 13.5 les-
ions (2~19). All the patients had been treated with a surgical
resection for the largest cystic or solid masses prior to radiosur-
gery. Each lesion volume varied from 4.1 to 5500mm3 (mean
338.9mm3). The mean dose delivered to the tumor margin was
16.7Gy(12.8~29.75Gy) and the isodose margin varied from
40% to 95% (mean 60.2%).
Results
Seven patients were manifested as multiple lesions from theinitial diagnosis. In one patient, all three lesions were res-
ected by first surgery (Case 3). However, the other six patients
required additional treatment due to the residual tumors. One
patient refused additional treatment (Case 4). One patient who
already had lower cranial nerve deficits died from aspiration
pneumonia 8years after the first surgery (Case 5). One patient
showed leptomeningeal dissemination into the intracranial
and spinal subarachnoid space 8years after the complete resec-
tion of a solitary cerebellar hemangioblastoma (Case 8). This
patient was treated with craniospinal irradiation. Two patients
were treated twice with radiosurgery and one of these two pa-
tients suffered from delayed radiation induced complications
and required posterior fossa decompression and ventriculop-
eritoneal shunt (Case 6). The treatment methods and its results
are summarized in Table 1.
Surgical resection
A total of 13 procedures were performed on nine patients
with multiple hemangioblastomas in the posterior cranial fossa.
A total of 16 lesions were treated with a surgical resection.
Ten lesions were resected subtotally and required additional
radiosurgery. Six lesions were controlled by the first surgery.
Only one patient with 3 lesions at the initial diagnosis could
be cured by the first surgery, and this patient has been reviewed
in an outpatient clinic for 56.3mo-
nths without a recurrence (Case 3).
Radiosurgical response
Among the total 81 lesions treated
by radiosurgery, 10 lesions were
post-operative remnants, 2 lesions
were mainly cystic and the others
were all small solid tumors. Seventy-
nine lesions out of 81 lesions were
controlled, which means that the
lesions were disappeared (complete
response, 3.8%) or shrunk (partial
response, 6.3%) or unchanged (st-
able, 89.9%). Only two lesions fa-
iled to be controlled. One lesion was
a post-operative remnant that was
part of an initially symptomatic
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Table 1. Summary of treatments and results for multiple hemangioblastomas
Case Age/ Surgical 
GKS*
Follow-up
No. sex resection
Lesion Volume Dose
(month)
Results
No. (mm3)† (Gy)‡
1 40/M 1+1** 6 1570 14.0 154.3 Controlled
2 45/M 1 6 1067 19.8 33.0 Controlled
3 45/M 3 - - - 56.3 Controlled
4 34/F 1 - - - 6.6 Residual tumors
Refusal of treatment
5 31/F 1+1** 2 2539 14.5 91.5 Controlled 
died (aspiration pneumonia)
6 22/F 1+1** 14+17*** 54 17.5 77.8 1 surgical remnant - GKS failure
Radiation induced complication
7 19/M 1+2** 7+10*** 221 17.7 159.2 1 cyst - GKS failure Controlled
8 45/F 1 - - - 96.1 Leptomeningeal seeding
` Cranio-spinal irradiation
9 18/M 1 19 59 16.6 6.7 Controlled
*GKS : gamma knife radiosurgery, **Surgical resection in twice and the number of resected lesions, ***GKS in twice
and the number of treated lesions,† The volume of multiple tumors are mean value,‡ Marginal dose
A B
Fig. 1.Case 7 : Axial gadolinium enhanced T1 weighted magnetic
resonance(MR) images. Pre-radiosurgical MR images(A) showing
a small cystic tumor in the right cerebellar hemisphere. Post-
radiosurgical MR images(B) 29months after the radiosurgery showing
the enlargement of tumor.
large cyst with a volume of 340mm3 and was treated with a
margin dose of 17.5Gy. This lesion eventually grew to a large
cyst requiring an additional surgical resection. The other les-
ion was 1.8cm in diameter when radiosurgery was performed
with a 50% margin dose of 17.4Gy. Twenty-nine months after
the radiosurgery, the cyst had enlarged to 3.7cm in diameter
and needed to be resected surgically (Fig. 1).
Illustrative Cases
Case 2
This 45-year-old male presented with headache in 2000,
and the MR imaging revealed 6 lesions in the posterior fossa.
All the lesions were solid and one lesion was removed partially
because the tumor was contacted to the brain stem. Including
this surgical remnant, all six lesions were treated with radiosur-
gery 8months later. MR imaging was followed 2years after
radiosurgery, which revealed that all lesions had shrunk or
unchanged (Fig. 2). This patient has been reviewed in an
outpatient clinic for 33months.
Case 6
A 22-year-old female patient showed 14 lesions in bilateral
ce-rebellar hemisphere. Because of the scattered numerous
lesions, she underwent a partial excision of the largest cystic
hemangiobla-stoma, which was followed with GKS for 14
small tumors including one surgical remnant. The dose delivered
to the tumor margin was 17.5Gy at a 70% isodose line. Six
years after GKS, progressive headache and vomiting prompted
her to visit the emergency room. MR imaging revealed a rec-
urrent cystic lesion that measured 5.2cm in diameter, and th-
ere were new small and scattered lesions. The cyst was drained
and the 16 countable lesions were treated by GKS at 70% iso-
dose of 17.5Gy. At 6months after the second GKS, she revis-
ited the emergency room due to vomiting and a change in her
mental status. MR imaging demonstrated severe posterior fossa
swelling and obstructive hydrocephalus. Decompression and
a ventriculoperitoneal shunt were
performed. Six months after the
decompression she was discharged
from hospital. She could walk in-
dependently and take care of he-
rself with assist. However, cerebe-
llar ataxia and intermittent dizzin-
ess were still remained (Fig. 3).
Case 8
In 1995, a 45-year-old female pr-
esented with a solitary cerebellar
mass. The tumor was resected co-
mpletely and the pathology reve-
aled a hemangioblastoma. Eight
years later, in 2003, she developed
headache and vomiting. An imag-
ing study demonstrated multiple
leptomeningeal seeding in the
posterior cranial fossa and in the
cervical, thoracic regions of the
spinal cord (Fig. 4). She received
cranio-spinal irradiation with a
dose of 3600cGy to the whole
spinal cord and 5940 cGy to the
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Fig. 3.Case 6 : Axial gadolinium enhanced T1 and T2 weighted magnetic resonance(MR) images
and computed tomography(CT). A : MR images on the first radiosurgery showing multiple tumors
in the cerebellum. B : MR images six years after the first radiosurgery showing a large cystic lesions
in left cerebellum, which needed surgical resection later. C and D : MR images on the second
radiosurgery showing the resolution of previously treated tumors but also newly developed
tumors. E and F : MR images revealing severe cerebellar swelling, so decompressive craniectomy
is performed eight months after the second radiosurgery.
A B
Fig. 2.Case 2 : Axial gadolinium enhanced T1 weighted magnetic
resonance (MR) images. Preoperative MR images(A) showing
multiple tumors in the cerebellar hemisphere and inferior vermis.
Postoperative MR image(B) two years after radiosurgery showing
that one is shrunken and another two unchanged.
posterior fossa. She has been followed up in an outpatient
clinic for 7months.
Discussion
Hemangioblastomas show a tendency to develop at mu-ltiple sites in the CNS. In particular, these characteristics
of multiplicity are very prominent in VHL disease. Moreover,
these tumors usually grow progressively. Wanebo et al.18) revi-
ewed the serial MR imaging studies of 160VHL disease pa-
tients with CNS tumors, and over a median of 32months, 44%
of tumors and 67% of the tumor-associated cysts were enlarged.
There was no spontaneous regression or shrinkage of the tumor.
Because most hemangioblastomas occur in the very narrow space
of posterior cranial fossa, significant increase in the intracranial
pressure and neurological deficit can developed. Therefore,
these multiple lesions need to be treated actively in the early
stage.
Surgical resection of hemangioblastoma
For solitary tumors, a gross total surgical resection results in
excellent rates of control and has been the treatment of choice
historically5). However, a complete resection is difficult when
there are more than one lesion. Among the 16 lesions treated
with surgical resection, only six lesions were resected comple-
tely without recurrence. Surgical resection is preferable when
the lesion was cystic. Niemela et al.12) described the radiosur-
gical results of solid or cystic hemangioblastomas. Whereas all
the 10 solid lesions either shrank or were unchanged, 3 lesions
of 5 adjoining cyst lesions needed to be evacuated after radio-
surgery. Among the three cystic lesions treated with GKS in
our series, two lesions could not be controlled and required a
surgical resection, and one lesion showed no interval change.
In the cases with large tumors, and so if they cause neurologi-
cal symptoms or deficits, immediate surgical decompression
is preferable.
Radiosurgery of hemangioblastoma
Although a surgical resection is the ideal treatment for hem-
angioblastomas, there are some limitations in treating multiple,
progressive and recurrent hemangioblastomas, because exten-
sive and repeated surgical exposures can cause cumulative ne-
urological damage. Smalley et al.16) reported the radiosurgical
experience of 22 multiple hemangioblastomas in 7patients.
With a median volume of 965mm3 (50~12000mm3) and a
median margin dose of 15.5Gy (12~20Gy), all lesions were
controlled after a median follow-up of 24months. Patrice et
al.14) reported an 86% local control rate at two years. In their
reports, there was no local failure of lesions below 3cc in volume,
and they used a margin dose of 17Gy or more on 35 tumors
at a median follow-up of 24.5months. Jawahar et al.4) reported
that 22 out of 29 lesions were controlled at a mean follow-up
of 4years. They emphasized that a smaller tumor volume and
a higher dose (＞18Gy) were the significant affecting factors
for a good outcome. In our current series, only two out of
eighty one lesions failed to be controlled. The follow up dur-
ation of the patients who were treated with radiosurgery was
87.1months (6.7~159.2months). Compared with previous
reports, the margin dose of 16.7Gy is similar. However, the
mean tumor volume of 11.3mm3 was much smaller, which
would lead to a good local control rate. Our current series had
a relative large number of lesions in each patient, but they
could also be controlled successfully due to the small tumor
volume. Although there are multiple lesions in the narrow
posterior cranial fossa, small lesions can be controlled if found
in the early stage.
Multiple hemangioblastomas and post-radiation 
brain swelling
In 1993, Page et al.13) reported a patient who was suffered
from cerebellar edema due to radiation necrosis after radio-
surgery. In this case, four lesions in the cerebellum were tre-
ated by radiosurgery with 35Gy of a margin dose, and the
patient required glucocorticoids medication and a ventriculo-
peritoneal shunt. In 1996, Niemela et al.12) reported 11cases
that had been treated with radiosurgery. The median margin
dose in the first 6cases was 25Gy and the median margin dose
in the later 5cases was only 10Gy. One patient with two lesi-
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Fig. 4. Case 8 : Axial gadolinium
enhanced T1 weighted mag-
netic resonance images sho-
wing multiple leptomeningeal
seeding in the posterior fossa
and in the cervical and thoracic
regions of the spinal cord.
C
ons received a margin dose of 25Gy and developed radiation
edema 6months later. This patient required a ventriculoperi-
toneal shunt and prolonged corticosteroid medication. The
authors suggested that a margin dose of 10 to 15Gy might
be sufficient to shrink or control the solitary small or medium
sized lesions. In case 6 from the present study, the margin dose
was 17.5Gy but she had several risk factors for developing
brain swelling; a large number of lesions (14+17), using a
large diameter collimator (8mm) and two times of the radio-
surgery procedures. Therefore, the proper margin dose alone
is insufficient for preventing post-radiation brain swelling
because the radiation field might have been be overlapped
due to the multiple radiation shots. The use of a small colli-
mator may be helpful because it makes the dose gradient ste-
eper. Through a regular follow-up imaging study and proper
screening, an early diagnosis in the high-risk group must be
made for early radiosurgical intervention before the tumors
can grow.
Leptomeningeal hemangioblastomatosis
Mohan et al.9) reported two cases of disseminated hemang-
ioblastomatosis in 1976, who had multiple sites of subarach-
noid dissemination and progressive growth with a poor out-
come. These two patients had a history of a prior surgical re-
section of a solitary cerebellar hemangioblastoma, each 8 and
14years ago, and lacked the clinical or familial evidence of
VHL disease. Reyns et al.15) also reported a 51-year-old man
with diffuse CNS hemangioblastomatosis that occurred after
three times of surgical resection for recurrent solitary cerebell-
ar hemangioblastoma. After 7years from the last surgery, he
showed dissemination into the whole intracranial and spinal
subarachnoid spaces and died 6months later. Weil et al.19) pre-
sented four patients with no family history or clinical evidence
of VHL disease in whom extensive, progressive, en plaque
coating of the brain stem and spinal cord with hemangiobl-
astomas developed 1 to 8years after the complete resection of
a solitary cerebellar hemangioblastoma. Despite surgery, rad-
iation therapy, and systemic drug therapy, these patients sho-
wed progressive clinical deterioration over the course of app-
roximately 1 to 2years after presentation with recurrent tum-
ors, even though the histological appearance was typical ben-
ign hemangioblastomas. The authors suggested that this syn-
drome appeared to result from the delayed growth of subara-
chnoid tumor cells disseminated by surgery and one or more
other genes appeared to contribute to the unusual malignant
behavior. In our case (Case 8), the patient also had a history
of prior surgery, and the MR imaging study demonstrated
multiple leptomeningeal seeding in the posterior fossa and in
the cervical, thoracic regions of the spinal cord. There may be
no difference between sporadic and VHL-associated tumors
with respect to dissemination2,8,19). Disseminated hemangiob-
lastomatosis have a biological, clinical, and molecular genetic
profile that is distinct from the hemangioblastomas associated
with VHL disease9,15,19). Therefore, it should be treated as for
different disease entity.
Conclusion
Hemangioblastomas are benign tumor histologically,which means that long life expectancy is expected. If
treated by proper modalities with careful consideration, they
can be controlled even if there are multiple lesions. Further
research on a more targeted therapeutic modality is expected
to advance the treatment of multiple hemangioblastomas. 
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Commentary
Multiple hemangioblastoma with von Hippel-Lindau(VHL) disease can be difficult to manage surgically alone
as it differs from the solitary hemangioblastoma, which has lead
to an interest in applying of stereotactic radiosurgery.
The article provides information on retrospectively collective
cases of multiple hemangioblastoma, guiding the treatment strategy
what we have to handle them. This report present that they have
treated nine patients with VHL disease, confined in posterior cranial
fossa, and operated 16 lesions, and taken 81 lesions into the Gamma
knife. After radiosurgery with mean follow time of 75.7months,
there was an excellent controlled rate in 79 of 81 lesions. However,
authors have expe-rienced two complicated patients, one is
recurrent large cystic lesion with increased scattered lesions, and
the other is multiple leptomeningeal seeding around posterior
fossa and in spinal column as rarely reported.
Generally multiple hemangioblastoma is closely linked to VHL
disease which has been investigated as germline mutation of the
VHL tumor supressor gene on chromosome three, region p
25~26 with an estimated incidence of one in 36,000 newborns.
Patients with VHL disease are at risk of developing cerebellar,
spinal and retinal hemangioblastoma, renal cell carcinoma,
pheochromocy-toma, pancreatioc neuroendocrine tumors,
pancreatic and renal cyst.
Hemangioblastoma in posterior cranial fossa, if presented in
progress, induces rapid neurological deterioation in which enco-
untered into rapid surgical resection of lesions as possible. In cases
of  multiple hemangioblastoma, although it revealed the growth
phase and arrested quiscent phase in natural history, the lesions
to be unable to remove surgically whether located near brain stem
or scattered widely, would be manage in any measure because
the lesion is going to grow progressively. It is necessary that an
optimal clinical and radiological follow-up give a clue to appro-
priate treating strategy.
This paper in here present the local tumor control was achieved
in majority of cases with radiosurgery following surgical removal
with disclosing 79 of 81 lesions control in long term follow up
duration of mean Six years. Radiosurgery is a useful palliative mea-
sure controlling multiple lesions on diagnosis or later in course, alt-
hough further disease to develop or progressive intracranially is
limited in its efficacy in these patients.
Young Soo Ha, M.D.
Kwandong University College of Medicine
Myongji Hospital
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